Alzheimer’s patients divided on Adulheim, costly new drug; A ‘magic pill’ or ‘risk I’m willing to take’ - Chicago Sun-Times

Medicare has proposed limiting coverage of Aduhelm. Key groups representing patients and families are pressing to make it more widely available. Among people facing the disease, the outlook is more nuanced.

If you listen to the nations largest Alzheimers disease advocacy organizations, you might think everyone living with Alzheimers wants unfettered access to Aduhelm, a controversial new treatment. But… [+9837 chars]

full article...